The Unitaid Plus Project looks forward to participating in the 74th Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH), from November 9th \u2013 13th. We are proud to present poster presentations highlighting the innovations, strategies, and lessons learned generated by activity in project-supported countries: Benin, Cameroon, C\u00f4te d\u2019Ivoire, and Mozambique. We are also thrilled to co-host a symposium with Malaria Consortium about lessons learned implementing PMC across Benin, Cameroon, Cote d’Ivoire, Mozambique, and Nigeria. <\/p>\n\n\n\n
See below for a full list of our submissions and follow us on LinkedIn<\/a> for updates throughout the week.<\/p>\n\n\n\n Scientific Symposium<\/span><\/strong><\/p>\n\n\n\n (105) Results from large-scale implementation of perennial malaria chemoprevention (PMC) in Benin, Cameroon, C\u00f4te d’Ivoire, Mozambique and Nigeria<\/strong><\/p>\n\n\n\n Tuesday, November 11 at 4:00 PM Eastern<\/p>\n\n\n\n Convention Center – Room 718B (Level 7)<\/p>\n\n\n\n More information<\/a><\/p>\n\n\n\n .<\/p>\n\n\n\n Oral Presentations<\/span><\/strong><\/p>\n\n\n\n (6090) Innovations in mobile data capture for multi-country implementation of a longitudinal malaria chemoprevention study in Cameroon and Cote d\u2019Ivoire<\/strong><\/p>\n\n\n\n Session: <\/strong>27 – Global Health: Improved Health Care Service Delivery and Health Systems Strengthening<\/a><\/p>\n\n\n\n Monday, Nov. 10th at 10:55 AM Eastern<\/p>\n\n\n\n Convention Center – Room 801A (Level 8)<\/p>\n\n\n\n More information<\/a><\/p>\n\n\n\n (7167) Barriers to Essential Programme on Immunisation Coverage and Implications for Perennial Malaria Chemoprevention in Infants: Evidence from census surveys in Cameroon and C\u00f4te d’Ivoire<\/strong><\/p>\n\n\n\n Session: <\/strong>92 – Global Health: Women’s, Maternal, Newborn, Child, and Adolescent Health<\/a><\/p>\n\n\n\n Tuesday, Nov. 11th at 2:55 PM Eastern<\/p>\n\n\n\n Convention Center – Room 801A (Level 8)<\/p>\n\n\n\n More information<\/a><\/p>\n\n\n\n (7190) Geographical Variation in Sulfadoxine-Pyrimethamine Resistance Markers and Implications for Malaria Chemoprevention in Cameroon<\/strong><\/p>\n\n\n\n Session: <\/strong>98 – Malaria – Current Trends in Antimalarial Drug Resistance<\/a><\/p>\n\n\n\n Tuesday, Nov. 11th at 4:10 PM Eastern<\/p>\n\n\n\n Convention Center – Room 701B (Level 7)<\/p>\n\n\n\n More information<\/a><\/p>\n\n\n\n .<\/p>\n\n\n\n Poster Presentations<\/span><\/strong><\/p>\n\n\n\n (6315) Surveillance of antimalarial resistance markers to inform SP suitability for perennial malaria chemoprevention in C\u00f4te d\u2019Ivoire<\/strong><\/p>\n\n\n\n Monday, Nov. 10th at 12:30 PM Eastern<\/p>\n\n\n\n Poster Session A<\/p>\n\n\n\n Convention Center – Hall E (Level 8) (Poster Hall)<\/p>\n\n\n\n See abstract<\/a><\/p>\n\n\n\n (6317) Mapping antimalarial drug resistance markers in Plasmodium falciparum isolates across Benin<\/strong><\/p>\n\n\n\n Monday, Nov.10th at 12:30 PM Eastern<\/p>\n\n\n\n Poster Session A<\/p>\n\n\n\n Convention Center – Hall E (Level 8) (Poster Hall)<\/p>\n\n\n\n See abstract<\/a><\/p>\n\n\n\n (6393) Social determinants of health and the risk of malaria infection in a cohort study of perennial malaria chemoprevention in Cameroon: A causal mediation analysis<\/strong><\/p>\n\n\n\n Monday, Nov.10th at 12:30 PM Eastern<\/p>\n\n\n\n Poster Session A<\/p>\n\n\n\n Convention Center – Hall E (Level 8) (Poster Hall)<\/p>\n\n\n\n See abstract<\/a><\/p>\n\n\n\n (6402) Health Worker Perceptions of Malaria Vaccine and Perennial Malaria Chemoprevention Co-implementation<\/strong><\/p>\n\n\n\n Monday, Nov. 10th at 12:30 PM Eastern<\/p>\n\n\n\n Poster Session A<\/p>\n\n\n\n Convention Center – Hall E (Level 8) (Poster Hall)<\/p>\n\n\n\n See abstract<\/a><\/p>\n\n\n\n (6411) Do three additional PMC doses affect uptake of vitamin A supplementation in Cameroon? A novel comparative-interrupted time series analysis<\/strong><\/p>\n\n\n\n Monday, Nov. 10th at 12:30 PM Eastern<\/p>\n\n\n\n Poster Session A<\/p>\n\n\n\n Convention Center – Hall E (Level 8) (Poster Hall)<\/p>\n\n\n\n See abstract<\/a><\/p>\n\n\n\n (6416) Integrating evidence from novel chemoprevention trials to estimate protective efficacy of sulfadoxine-pyrimethamine against malaria parasites across different sub-Saharan Africa resistance profiles.<\/strong><\/p>\n\n\n\n Monday, Nov. 10th at 12:30 PM Eastern<\/p>\n\n\n\n Poster Session A<\/p>\n\n\n\n Convention Center – Hall E (Level 8) (Poster Hall)<\/p>\n\n\n\n See abstract<\/a><\/p>\n\n\n\n (6710) An interactive user-editable web-based app to inform context-adapted, cost-effective policy choices in heterogeneous settings: The perennial malaria chemoprevention decision support tool.<\/strong><\/p>\n\n\n\n Tuesday, Nov. 11th at 12:00 PM Eastern<\/p>\n\n\n\n Poster Session B<\/p>\n\n\n\n Convention Center – Hall E (Level 8) (Poster Hall)<\/p>\n\n\n\n See abstract<\/a><\/p>\n\n\n\n (6877) Prevalence of Pfdhps and Pfdhfr genetic markers associated with antimalarial drug resistance in two temporal cohorts in the Democratic Republic of Congo and implications for chemoprevention<\/strong><\/p>\n\n\n\n Tuesday, Nov. 11th at 12:00 PM Eastern<\/p>\n\n\n\n Poster Session B<\/p>\n\n\n\n Convention Center – Hall E (Level 8) (Poster Hall)<\/p>\n\n\n\n See abstract<\/a><\/p>\n\n\n\n (6880) Nationwide Surveillance of Molecular Markers of Antimalarial Resistance in Ghana<\/strong><\/p>\n\n\n\n Tuesday, Nov. 11th at 12:00 PM Eastern<\/p>\n\n\n\n Poster Session B<\/p>\n\n\n\n Convention Center – Hall E (Level 8) (Poster Hall)<\/p>\n\n\n\n See abstract<\/a><\/p>\n\n\n\n (6961) The secondary benefits of providing malaria chemoprevention to infants and children<\/strong><\/p>\n\n\n\n Tuesday, Nov. 11th at 12:00 PM Eastern<\/p>\n\n\n\n Poster Session B<\/p>\n\n\n\n Convention Center – Hall E (Level 8) (Poster Hall)<\/p>\n\n\n\n See abstract<\/a><\/p>\n\n\n\n (6983) Reaching children in the second year of life with perennial malaria chemoprevention (PMC): Opportunities and challenges from Benin, C\u00f4te d’Ivoire and Cameroon<\/strong><\/p>\n\n\n\n Tuesday, Nov. 11th at 12:00 PM Eastern<\/p>\n\n\n\n Poster Session B<\/p>\n\n\n\n Convention Center – Hall E (Level 8) (Poster Hall)<\/p>\n\n\n\n See abstract<\/a><\/p>\n\n\n\n (7471) Emergence of a validated Plasmodium falciparum Kelch 13 mutation (A675V) associated with artemisinin partial resistance and low prevalence of pfhrp2\/3 deletions in Cameroon<\/strong><\/p>\n\n\n\n Wednesday, Nov. 12th at 11:00 AM Eastern<\/p>\n\n\n\n Poster Session C<\/p>\n\n\n\n Convention Center – Hall E (Level 8) (Poster Hall)<\/p>\n\n\n\n See abstract<\/a><\/p>\n\n\n\n (7566) Time from asymptomatic malaria infection to onset of symptoms in retrospective PCR analysis of samples collected among children over 63 days: Evidence from two randomised placebo-controlled trials of malaria chemoprevention in Zambia and Cameroon<\/strong><\/p>\n\n\n\n Wednesday, Nov. 12th at 11:00 AM Eastern<\/p>\n\n\n\n Poster Session C<\/p>\n\n\n\n Convention Center – Hall E (Level 8) (Poster Hall)<\/p>\n\n\n\n See abstract<\/a><\/p>\n\n\n\n (7571) Implementation of perennial malaria chemoprevention in Cameroon: coverage, equity of coverage and change in coverage of co-interventions<\/strong><\/p>\n\n\n\n Wednesday, Nov. 12th at 11:00 AM Eastern<\/p>\n\n\n\n Poster Session C<\/p>\n\n\n\n Convention Center – Hall E (Level 8) (Poster Hall)<\/p>\n\n\n\n